Reneo Pharmaceuticals’ Common Stock Offering

Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents.Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 6,875,000…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now